Organic Process Development » Discussions

Ph.D

Bookmark and Share




The US FDA has issued full approval for Israeli drugmaker Teva’s Synribo (omacetaxine mepesuccinate)高三尖杉酯碱 for chronic myeloid leukaemia (CML).

Feb 18, 2014 | 16:02

No comments  

You should sign in or sign up for comment this post